The Report Genome Editing Market Analysis By Technology (CRISPR, TALEN, ZFN), By Delivery
Method (Ex-vivo, In-vivo), By Application (Animal/Plant Cell Editing), By
Service (In-house, Outsourced), By End-use And Segment Forecasts, 2018 – 2025
The global genome editing market is
anticipated to reach USD 8.1 billion by 2025, according to a new report by
Grand View Research, Inc. Key drivers attributing to the expansion include
early applications of DNA editing to therapeutics. Use of the technology for
the disease eradication through direct correction of disturbances in normal
physiology, engineering the immune response, and alteration of pathogen targets
in the host is anticipated to drive the market with substantial opportunities.
The
ability of genome editing therapies to offer a significant improvement over
current treatment options is important in enabling editing technologies to
capture significant revenue share. Improved efficacy, reduced side effects, and
the potential for cure for specific diseases, can be attributed to induce
growth in the coming years.
Moreover,
technological advancements with respect to the development of novel vectors for
delivery is anticipated to fuel growth in the coming years. Rising competition
amongst the operating entities in order to gain the larger share of revenue is
also responsible for the projected growth. These companies leverage industry
collaborations for the acceleration of diversified product pipelines.
Access Research Report of Genome Editing Market @ www.grandviewresearch.com/industry-analysis/genome-editing-market
Further Key Findings
from the Report Suggest:
· There has been great excitement surrounding the highly
adaptable CRISPR technology.
· The increased ease of retargeting and the ability to
multiplex goes a long way toward explaining the speed with which CRISPR-centric
companies have sprung up.
· Ex-vivo mode of delivery accounted for the largest share
of the revenue.
· Therapy through ex-vivo mode of delivery allow the
control over the specific dosage of therapeutic molecules delivered to cells.
· Cell line engineering dominated with respect to revenue
generation owing to the high utilization of technology in stem cell
engineering.
· There is comparatively, higher adoption of the technology
in the biotechnology and pharmaceutical organizations for the purpose of
therapeutic development.
· Availability of other services such as gRNA library
production and screening service along with editing is anticipated to propel
growth in the outsourcing services.
· Asia Pacific is anticipated to witness fastest growth
over the forecast period owing to rising penetration of technology in
comparatively immature market.
· Key players contributing in this market are Thermo Fisher
Scientific, Inc., Sangamo, Editas Medicine, Recombinetics, Inc, Sigma Aldrich
Corporation, CRISPR THERAPEUTICS, Intellia Therapeutics, Inc., Caribou
Biosciences, Inc.
· These participants are capitalizing on unique advantages
offered by the nuclease technology, they are working on.
Grand View Research has segmented the molecular
scissors/genome editing market on the basis of technology, delivery method,
application, end-use, service, and region:
Molecular
Scissors/Genome Editing Technology Outlook (Revenue, USD Million, 2014 - 2025)
·
(CRISPR)/Cas9
·
TALENs/MegaTALs
·
ZFN
·
Others
Molecular
Scissors/Genome Editing Delivery Method Outlook (Revenue, USD Million, 2014 -
2025)
·
Ex-Vivo
·
In-Vivo
Molecular
Scissors/Genome Editing Application Outlook (Revenue, USD Million, 2014 - 2025)
·
Cell Line Engineering
·
Animal Genetic Engineering
·
Plant Genetic Engineering
·
Other Applications
Molecular
Scissors/Genome Editing End-use Outlook (Revenue, USD Million, 2014 - 2025)
·
Biotechnology & Pharmaceutical Companies
·
Academic & Government Research Institutes
·
Contract Research Organizations
Molecular
Scissors/Genome Editing Service Outlook (Revenue, USD Million, 2014 - 2025)
·
Contract
·
In-house
Molecular
Scissors/Genome Editing Service Outlook (Revenue, USD Million, 2014 - 2025)
·
North America
o U.S.
o Canada
·
Europe
o Germany
o UK
·
Asia Pacific
o Japan
o China
·
Latin America
o Brazil
·
Middle East and Africa (MEA)
o South
Africa
Access
Press Release of Genome Editing Market @ www.grandviewresearch.com/press-release/global-genome-editing-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
No comments:
Post a Comment